Pursuant to Regulation 30 SEBI (LODR) Regulation 2015- Change in Management
HIKAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 11.5 pts less than Nifty Microcap 250 and 11.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Hikal Ltd disclosed two separate matters. First, it appointed Mr. Ravi Khadabadi as President – Crop Protection & Specialty Chemicals, effective May 27, 2026. He holds master's degrees in chemistry and Polymers from Mumbai and the University of Massachusetts Lowell, USA, and brings extensive experience in the Pharma and Specialty Chemicals industries. Second, in a follow-up to a December 2025 disclosure, the company provided details on an internal revenue recognition irregularity identified as of September 30, 2025. An external expert's fact-finding review concluded that the issue was limited to the early timing of genuine sales (revenue preponement) and was corrected within that quarter. The employees involved were identified and terminated. Management states there is no impact on current or previous periods.
The appointment of a senior business head signals new leadership direction for the Crop Protection division. The fraud disclosure, while handled internally, raises concerns about internal controls around revenue recognition, though management's conclusion of no financial impact may limit market reaction.